Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O4KI
|
|||
| Former ID |
DNC008472
|
|||
| Drug Name |
2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine
|
|||
| Synonyms |
CHEMBL407650; 2-ethyl-4-(2-thiazolyl)thieno[3,2-d]pyrimidine; 443148-33-2; SCHEMBL3674131
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H9N3S2
|
|||
| Canonical SMILES |
CCC1=NC2=C(C(=N1)C3=NC=CS3)SC=C2
|
|||
| InChI |
1S/C11H9N3S2/c1-2-8-13-7-3-5-15-10(7)9(14-8)11-12-4-6-16-11/h3-6H,2H2,1H3
|
|||
| InChIKey |
YNBYJWXOQPYWEM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives. Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.